# FDA Inspection 1197144 - George Aaron DuVall, M.D. - January 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/george-aaron-duvall-md/49870acb-8b5e-4a51-8d60-4b90445ab626
Source feed: FDA_Inspections

> FDA Inspection 1197144 for George Aaron DuVall, M.D. on January 20, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1197144
- Company Name: George Aaron DuVall, M.D.
- Inspection Date: 2023-01-20
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1159799 - 2021-12-09](https://www.keypedia.com/records/fda_inspections/george-aaron-duvall-md/69bedf79-b08d-41e0-afe9-09e3db5c1f9d)

Company: https://www.keypedia.com/companies/george-aaron-duvall-md/6c957d02-4f15-40f4-8644-ed35d333dc0f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c